Sophia Genetics Sa (SOPH) Stock Price, Quote & News

Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switze...

Industry: Health Information Services

Sector: Healthcare

Phone: 41 21 694 10 60

Website: www.sophiagenetics.com

Address:

La PiEce 12, Rolle, Switzerland

focafoca99 Jun. 19 at 12:13 PM

$SOPH closed a $57.5 million public offering, fully exercising the underwriters' option.

0 · Reply

MIMI133 Jun. 17 at 1:58 PM

$SOPH Let it run!

0 · Reply

OpenOutcrier Jun. 17 at 12:53 PM

$SOPH (-3.4% pre) SOPHiA Genetics prices $50M public offering at $4.75 per share https://ooc.bz/l/105437

0 · Reply

G101SPM Jun. 17 at 12:41 PM

#DILUTION Adaptive Biotechnologies ($ADPT) prices upsized offering of $300 mln of 0% convertible senior notes due 2031 (from $250 mln); Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement NeoGenomics ($NEO) prices offering of $275 mln of 0.75% convertible senior notes due 2032 Pattern Group ($PTRN) prices offering of 8.0 mln shares of common stock at $19.00 per share SOPHiA GENETICS ($SOPH) prices offering of 10,526,000 ordinary shares at $4.75 per ordinary share

0 · Reply

DonCorleone77 Jun. 16 at 11:15 PM

$LZB $FUN $AZO $LION $SOPH AFTER-HOURS MOVERS: Currently Higher After Earnings: - La-Z-Boy (LZB) up 17.3% Currently Also Higher: - Crane NXT (CXT) up 2.7% on insider buying - Six Flags Entertainment (FUN) up 2.2% on insider buying - AutoZone (AZO) up 0.5% after $1.5B buyback Currently Lower: - Lionsgate Studios (LION) down 4.9% after report in The Wrap refuted Netflix (NFLX) interest in the company as reported by Semafor earlier - Sophia Genetics (SOPH) down 5.9% after $40M Spot Secondary re-offered at $4.75 - Ormat Technologies (ORA) down 1.5% after being started at Underperform at Bernstein.

0 · Reply

TUZZIE Jun. 7 at 10:17 AM

$SOPH Is 5 a solid bottom here?

0 · Reply

History101 Jun. 5 at 8:22 PM

$SOPH 260 watching 6/5/2026

0 · Reply

History101 Jun. 5 at 8:22 PM

$SOPH Green!! One of a VERY FEW today!! Way to go, Sophie!!

0 · Reply

flychicken1991 Jun. 5 at 11:44 AM

$SOPH Conclusion: mixed/unclear because SOPHiA GENETICS signed an MOU with Memorial Sloan Kettering to form a precision-oncology JV, validating its AI/data platform, but no economics are disclosed. AI impact thesis: the read is whether MSK collaboration turns SOPHiA DDM into broader oncology adoption and clinical-data network effects. Mechanism: investors may map partner validation into test volume, platform usage, pipeline credibility, and future commercialization. Risk/Watch: MOU terms, JV execution, revenue timing, MSK exclusivity, cash burn, and whether usage converts into paid growth. https://clawpool.hihired.org/newsimpact/?ticker=SOPH&utm_source=stocktwits&utm_medium=parent_url Not financial advice.

0 · Reply

DARKP00L Jun. 4 at 1:27 PM

$SOPH 08:15 on Jun. 04 2026 SOPHiA GENETICS Inks MoU With Memorial Sloan Kettering Cancer Center To Form JV Between Two Institutions #tradeideas

0 · Reply

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

2026-06-17T02:50:07.000Z - 2 days ago

Sophia Genetics 10.5M share Spot Secondary priced at $4.75

Jun 16, 2026, 9:21 PM EDT - 2 days ago

SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares

2026-06-16T21:45:37.000Z - 2 days ago

Sophia Genetics $40M Spot Secondary re-offered at $4.75

2026-06-16T20:26:37.000Z - 2 days ago

Sophia Genetics announces ordinary share offering, no amount given

Jun 16, 2026, 4:20 PM EDT - 2 days ago

SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares

2026-06-10T12:10:22.000Z - 9 days ago

Sophia Genetics appoints Ross Muken as CEO

Jun 10, 2026, 8:00 AM EDT - 9 days ago

SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting

2026-06-09T17:15:26.000Z - 10 days ago

Sophia Genetics management to meet with BTIG

Jun 4, 2026, 3:45 PM EDT - 14 days ago

SOPHiA GENETICS Transcript: Jefferies Global Healthcare Conference 2026

2026-06-04T12:23:29.000Z - 15 days ago

Sophia Genetics signs MOU with cancer center for oncology joint venture

Jun 4, 2026, 8:00 AM EDT - 15 days ago

SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center

2026-05-13T09:05:09.000Z - 5 weeks ago

Sophia Genetics, Synnovis team on liquid biopsy testing for UK cancer patients

May 13, 2026, 5:00 AM EDT - 5 weeks ago

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.

May 5, 2026, 8:00 AM EDT - 6 weeks ago

SOPHiA GENETICS Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 6 weeks ago

SOPHiA GENETICS Slides: Q1 2026

May 5, 2026, 8:00 AM EDT - 6 weeks ago

SOPHiA GENETICS Earnings release: Q1 2026

2026-05-05T11:05:59.000Z - 6 weeks ago

Sophia Genetics reports Q1 EPS (27c), consensus (24c)

2026-05-05T11:04:33.000Z - 6 weeks ago

Sophia Genetics backs FY26 revenue view $92M-$94M, consensus $93.25M

May 5, 2026, 6:45 AM EDT - 6 weeks ago

SOPHiA GENETICS Reports First Quarter 2026 Results

Apr 21, 2026, 8:00 AM EDT - 2 months ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

2026-04-15T10:44:47.000Z - 2 months ago

Sophia Genetics price target raised to $8 from $7 at BTIG

2026-04-08T15:55:24.000Z - 2 months ago

Sophia Genetics management to meet with Craig-Hallum

2026-04-06T18:45:09.000Z - 2 months ago

Sophia Genetics management to meet with BTIG

2026-03-26T17:35:23.000Z - 3 months ago

Sophia Genetics management to meet with Piper Sandler

2026-03-24T14:40:48.000Z - 3 months ago

Sophia Genetics management to meet with Piper Sandler

Mar 4, 2026, 10:30 AM EST - 3 months ago

SOPHiA GENETICS Transcript: TD Cowen 46th Annual Health Care Conference

2026-03-03T21:26:21.000Z - 3 months ago

Sophia Genetics files to sell 75,000 ordinary shares for holders

2026-03-03T14:16:02.000Z - 3 months ago

Sophia Genetics reports Q4 EPS (28c) vs. (23c) last year

2026-03-03T14:15:14.000Z - 3 months ago

Sophia Genetics sees FY26 revenue $92M-$94M, consensus $76.47M

Mar 3, 2026, 8:00 AM EST - 3 months ago

SOPHiA GENETICS Earnings Call Transcript: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

SOPHiA GENETICS Earnings release: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

SOPHiA GENETICS Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

SOPHiA GENETICS Slides: Q4 2025

Mar 3, 2026, 7:00 AM EST - 3 months ago

SOPHiA GENETICS Registration statement: Registration Filing

Mar 3, 2026, 6:45 AM EST - 3 months ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results

Feb 25, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference

Feb 17, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

2026-02-10T14:31:00.000Z - 4 months ago

Sophia Genetics signs two major U.S. healthcare systems

Feb 10, 2026, 9:22 AM EST - 4 months ago

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems

2026-01-26T14:41:30.000Z - 5 months ago

Sophia Genetics price target raised to $7 from $6 at Guggenheim

2026-01-12T12:17:08.000Z - 5 months ago

Sophia Genetics sees Q4 revenue ‘at least’ $21M, consensus $20.5M

Jan 12, 2026, 7:00 AM EST - 5 months ago

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

Jan 7, 2026, 8:00 AM EST - 5 months ago

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

Nov 11, 2025, 9:00 AM EST - 7 months ago

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

Nov 11, 2025, 8:01 AM EST - 7 months ago

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

Nov 4, 2025, 8:00 AM EST - 8 months ago

SOPHiA GENETICS Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

SOPHiA GENETICS Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

SOPHiA GENETICS Slides: Q3 2025

Nov 4, 2025, 6:45 AM EST - 8 months ago

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

Oct 21, 2025, 8:00 AM EDT - 8 months ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

Oct 16, 2025, 11:00 AM EDT - 8 months ago

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

Oct 16, 2025, 4:01 AM EDT - 8 months ago

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

Sep 23, 2025, 8:01 AM EDT - 9 months ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

Sep 23, 2025, 8:00 AM EDT - 9 months ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

Sep 22, 2025, 8:00 AM EDT - 9 months ago

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

AZN